학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 267건 | 목록
1~20
Academic Journal
Flack JM; Departments of Medicine and Population Science and Policy, Division of General Internal Medicine, Hypertension Section, Southern Illinois University, Springfield.; Azizi M; Université Paris Cité, INSERM Centre d'Investigation Clinique 1418, Paris.; Assistance Publique-Hôpitaux de Paris, Department of Hypertension, Hôpital Européen Georges Pompidou, Paris.; Brown JM; Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston.; Dwyer JP; Division of Nephrology and Hypertension, University of Utah, Salt Lake City.; Fronczek J; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals Research and Development, AstraZeneca, Warsaw, Poland.; Jones ESW; Department of Medicine, Division of Nephrology and Hypertension, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.; Olsson DS; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals Research and Development, AstraZeneca, Mölndal, Sweden.; Perl S; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals Research and Development, AstraZeneca, Gaithersburg, MD.; Shibata H; Department of Endocrinology, Metabolism, Rheumatology, and Nephrology, Faculty of Medicine, Oita University, Oita, Japan.; Wang JG; Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Wilderäng U; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals Research and Development, AstraZeneca, Mölndal, Sweden.; Wittes J; Wittes, Washington, DC.; Williams B; University College London Institute of Cardiovascular Science and National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London.
Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
Academic Journal
Flack JM; Departments of Medicine and Population Science and Policy, Southern Illinois University, Springfield, IL, USA. jflack47@siumed.edu.; Azizi M; Hypertension Department, Hôpital Européen Georges Pompidou, Paris, France.; Brown JM; Department of Medicine, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Dwyer JP; Division of Nephrology and Hypertension, University of Utah, Salt Lake City, UT, USA.; Jones ESW; Department of Medicine, Division of Nephrology and Hypertension, Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa.; Lihn AS; R&D BioPharmaceuticals, Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca, Gothenburg, Sweden.; Liu L; R&D China, Clinical Science, Cardiovascular, Renal, Metabolism (CVRM) and Safety, AstraZeneca, Shanghai, China.; Olsson DS; R&D BioPharmaceuticals, Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca, Mölndal, Sweden.; Perl S; R&D BioPharmaceuticals, Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca, Gaithersburg, MD, USA.; Shibata H; Department of Endocrinology, Metabolism, Rheumatology and Nephrology, Faculty of Medicine, Oita University, Oita, Japan.; Wang JG; The Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Wilderäng U; R&D BioPharmaceuticals, Late-Stage Development, Cardiovascular, Renal and Metabolism (CVRM), AstraZeneca, Mölndal, Sweden.; Wittes JT; Wittes LLC, Washington, DC, USA.; Williams B; Institute of Cardiovascular Science and National Institute for Health Research, UCL Hospitals Biomedical Research Centre, University College London, London, UK.
Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9307690 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1348-4214 (Electronic) Linking ISSN: 09169636 NLM ISO Abbreviation: Hypertens Res Subsets: MEDLINE
Academic Journal
Hazewinkel AD; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Gregson J; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom.; Pocock SJ; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, United Kingdom. Electronic address: stuart.pocock@lshtm.ac.uk.; McMurray J; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Claggett B; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Packer M; Baylor University Medical Center, Dallas, Texas, USA; Imperial College, London, United Kingdom.; Anker SD; Department of Cardiology, German Heart Center Charité, Universitätsmedizin Berlin, Berlin, Germany; Berlin Institute of Health Center for Regenerative Therapies, Berlin, Germany; German Centre for Cardiovascular Research partner site Berlin, Charité Universitätsmedizin, Berlin, Germany.; Ferreira JP; Cardiovascular Research and Development Center, Department of Surgery and Physiology, Faculty of Medicine, University of Porto, Porto, Portugal; Heart Failure Clinic, Internal Medicine Department, Unidade de Saude de Gaia-Espinho, Vila Nova de Gaia, Portugal; Université de Lorraine INSERM, Centre d'Investigations Cliniques Plurithématique, Nancy, France.; Docherty K; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; Henderson A; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; Jhund P; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; Wilderäng U; Late-Stage Development, Cardiovascular, Renal and Metabolism, R&D BioPharmaceuticals, AstraZeneca, Gothenburg, Sweden.; Wright D; Respiratory and Immunology Biometrics and Statistical Innovation, Biopharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.
Publisher: Elsevier Biomedical Country of Publication: United States NLM ID: 8301365 Publication Model: Print Cited Medium: Internet ISSN: 1558-3597 (Electronic) Linking ISSN: 07351097 NLM ISO Abbreviation: J Am Coll Cardiol Subsets: MEDLINE
Editorial & Opinion
ACTA ONCOLOGICA. 55(6):788-792
Academic Journal
Docherty KF; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Buendia Lopez R; Data Science, Late-Stage Development, Cardiovascular, Renal and Metabolic, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Folkvaljon F; HTA Statistics & Data Science, Biopharmaceuticals BBU, AstraZeneca, Barcelona, Spain.; Boer RA; Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands.; Chen J; AstraZeneca BioPharmaceuticals Research & Development, Late-stage Development, Cardiovascular, Renal and Metabolic, Gaithersburg, MD, USA.; Hammarstedt A; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals Research & Development, AstraZeneca, Gothenburg, Sweden.; Kitzman DW; Sections on Cardiovascular Medicine and Geriatrics/Gerontology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.; Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City, MO, USA.; Langkilde AM; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals Research & Development, AstraZeneca, Gothenburg, Sweden.; Reicher B; AstraZeneca BioPharmaceuticals Research & Development, Late-stage Development, Cardiovascular, Renal and Metabolic, Gaithersburg, MD, USA.; Senni M; University of Milano-Bicocca, Cardiovascular Department, Papa Giovanni XXIII Hospital, Bergamo, Italy.; Wilderäng U; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals Research & Development, AstraZeneca, Gothenburg, Sweden.; Verma S; Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.; Cowie MR; Late-Stage Development, Cardiovascular, Renal and Metabolic, BioPharmaceuticals R&D, AstraZeneca, Boston, MA, USA.; Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.; McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK. Electronic address: john.mcmurray@glasgow.ac.uk.
Publisher: Churchill Livingstone Country of Publication: United States NLM ID: 9442138 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8414 (Electronic) Linking ISSN: 10719164 NLM ISO Abbreviation: J Card Fail Subsets: MEDLINE
Academic Journal
Skoogh, Johanna; Ylitalo, N; Omerov, Pernilla; Hauksdóttir, A; Nyberg, U; Wilderäng, U; Johansson, B; Gatz, M; Steineck, Gunnar
Annals of Oncology. 21(9):1905-1909
Academic Journal
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 85(1):e29-e37
Academic Journal
Butt JH; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.; Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.; Kondo T; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Yang M; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.; Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.; Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.; Vaduganathan M; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Hernandez AF; Duke University Medical Center, Durham, NC, USA.; Lam CSP; National Heart Centre Singapore, Singapore.; Duke-National University of Singapore, Singapore.; Inzucchi SE; Yale School of Medicine, New Haven, CT, USA.; Martinez FA; University of Cordoba, Cordoba, Argentina.; de Boer RA; Erasmus Medical Center, Rotterdam, The Netherlands.; Kosiborod MN; Saint Luke's Mid America Heart Institute, Kansas City, MO, USA.; Desai AS; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Køber L; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Ponikowski P; Department of Heart Disease, Wroclaw Medical University, Wroclaw, Poland.; Sabatine MS; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Shah SJ; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Zaozerska N; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Wilderäng U; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Bengtsson O; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.
Publisher: Oxford University Press Country of Publication: England NLM ID: 8006263 Publication Model: Print Cited Medium: Internet ISSN: 1522-9645 (Electronic) Linking ISSN: 0195668X NLM ISO Abbreviation: Eur Heart J Subsets: MEDLINE
Academic Journal
Lundstedt, D; Gustafsson, M; Malmström, P; Johansson, K-A; Alsadius, D; Sundberg, A; Wilderäng, U; Holmberg, E; Anderson, H; Steineck, G
RADIOTHERAPY AND ONCOLOGY. 97(2):281-287
Academic Journal
Skoogh, Johanna, 1975; Steineck, Gunnar, 1952; Cavallin-Ståhl, E; Wilderäng, Ulrica; Håkansson, U K; Johansson, Boo; Stierner, Ulrika, 1952
International journal of andrology. 34(2):183-192
Academic Journal
McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, UK (J.J.V.M., K.F.D.).; Docherty KF; BHF Cardiovascular Research Centre, University of Glasgow, UK (J.J.V.M., K.F.D.).; de Boer RA; Department of Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, the Netherlands (R.A.d.B.).; Hammarstedt A; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals Research & Development, AstraZeneca, Gothenburg, Sweden (A.H., A.M.L., U.W.).; Kitzman DW; Sections on Cardiovascular Medicine and Geriatrics/Gerontology, Wake Forest University School of Medicine, Winston-Salem, NC (D.W.K.).; Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City (M.N.K.).; Maria Langkilde A; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals Research & Development, AstraZeneca, Gothenburg, Sweden (A.H., A.M.L., U.W.).; Reicher B; AstraZeneca BioPharmaceuticals Research & Development, Late-Stage Development, Cardiovascular, Renal and Metabolic, Gaithersburg, MD (B.R.).; Senni M; Cardiovascular Department, Papa Giovanni XXIII Hospital Bergamo, Italy (M.S.).; Shah SJ; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL (S.J.S.).; Wilderäng U; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals Research & Development, AstraZeneca, Gothenburg, Sweden (A.H., A.M.L., U.W.).; Verma S; Division of Cardiac Surgery, St Michael's Hospital, University of Toronto, Ontario, Canada (S.V.).; Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (S.D.S.).
Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0147763 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4539 (Electronic) Linking ISSN: 00097322 NLM ISO Abbreviation: Circulation Subsets: MEDLINE
Academic Journal
Alevronta, E.; Skokic, V.; Wilderäng, U.; Dunberger, G.; Sjöberg, F.; Bull, C.; Bergmark, K.; Steineck, G.
Radiotherapy and Oncology. 123:S870-S871
Academic Journal
Yang M; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Department of Cardiology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, China.; Butt JH; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Department of Cardiology, Copenhagen University, Copenhagen, Denmark.; Kondo T; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Jering KS; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.; Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.; de Boer RA; Erasmus Medical Center, Rotterdam, The Netherlands.; Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.; Desai AS; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.; Hernandez AF; Duke University Medical Center, Durham, NC, USA.; Inzucchi SE; Yale School of Medicine, New Haven, CT, USA.; Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City, MS, USA.; Lam CSP; National Heart Center Singapore and Duke-National University of Singapore, Singapore.; Langkilde AM; Late-Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals Research and Development, Gothenburg, Sweden.; Martinez FA; National University of Cordoba, Cordoba, Colombia.; Petersson M; Late-Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals Research and Development, Gothenburg, Sweden.; Shah SJ; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Vaduganathan M; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.; Wilderäng U; Late-Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals Research and Development, Gothenburg, Sweden.; Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA, USA.; McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Publisher: Wiley Country of Publication: England NLM ID: 100887595 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0844 (Electronic) Linking ISSN: 13889842 NLM ISO Abbreviation: Eur J Heart Fail Subsets: MEDLINE
Academic Journal
Adamson C; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.; Kondo T; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.; Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.; de Boer RA; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Cabrera Honorio JW; Clínica Vesalio, San Borja, Peru.; Claggett B; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Desai AS; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Alcocer Gamba MA; Centro de Estudios Clínicos de Querétaro (CECLIQ), Querétaro, México.; Al Habeeb W; Cardiac Sciences Department, King Saud University, Riyadh, Saudi Arabia.; Hernandez AF; Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.; Inzucchi SE; Section of Endocrinology, Yale University School of Medicine, New Haven, CT, USA.; Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City, Kansas City, MO, USA.; Lam CSP; Department of Cardiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; National Heart Centre Singapore & Duke-National University of Singapore, Singapore, Singapore.; Langkilde AM; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Lindholm D; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Bachus E; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Litwin SE; Division of Cardiology Medical University of South Carolina and Ralph H. Johnson, Veterans Affairs Medical Center, Charleston, SC, USA.; Martinez F; Cordoba National University, Cordoba, Argentina.; Petersson M; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Shah SJ; Division of Cardiology, Department of Medicine, and Bluhm Cardiovascular Institute, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.; Vaduganathan M; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Nguyen Vinh P; Cardiovascular Center, Tam Anh hospital, Tan Tao University, Ho Chi Minh City, Vietnam.; Wilderäng U; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, 126 University Place, Glasgow G12 8TA, UK.
Publisher: Oxford University Press Country of Publication: England NLM ID: 8006263 Publication Model: Print Cited Medium: Internet ISSN: 1522-9645 (Electronic) Linking ISSN: 0195668X NLM ISO Abbreviation: Eur Heart J Subsets: MEDLINE
Academic Journal
Radiotherapy and Oncology. 119:S7-S8
Academic Journal
Journal of Cancer Survivorship: Research and Practice. December 2013 7(4):652-658
Academic Journal
Haglind, E.; Carlsson, S.; Stranne, J.; Wallerstedt, A.; Wilderäng, U.; Thorsteinsdottir, T.; Lagerkvist, M.; Damber, J. E.; Bjartell, A.; Hugosson, J.; Wiklund, P.; Steineck, G.
The Journal of Urology. Sep 01, 2015 194(3):706-706
검색 결과 제한하기
제한된 항목
[검색어] WILDERÄNG, U.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어